ALDEYRA THERAPEUTICS, INC. Lessee, Operating Lease, Liability, to be Paid, Year One
ALDEYRA THERAPEUTICS, INC. (ALDX) had Lessee, Operating Lease, Liability, to be Paid, Year One of $147.28 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-06
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $147.28K.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $220.92K.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $294.56K.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $71.30K.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $147.28K 10-Q · filed 2026-08-06 |
| 2026-03-31 | $220.92K 10-Q · filed 2026-05-07 |
| 2025-12-31 | $294.56K 10-K · filed 2026-02-27 |
| 2025-09-30 | $71.30K 10-Q · filed 2025-11-05 |
| 2025-06-30 | $142.60K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $213.90K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $285.21K 10-K · filed 2025-02-28 |
| 2024-09-30 | $68.96K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $137.93K 10-Q · filed 2024-08-01 |
| 2024-03-31 | $206.89K 10-Q · filed 2024-05-02 |
| 2023-12-31 | $275.86K 10-K · filed 2024-03-07 |
| 2023-09-30 | $66.63K 10-Q · filed 2023-11-03 |
| 2023-06-30 | $133.25K 10-Q · filed 2023-08-03 |
| 2023-03-31 | $197.54K 10-Q · filed 2023-05-04 |
| 2022-12-31 | $261.83K 10-K · filed 2023-03-09 |
| 2022-09-30 | $63.12K 10-Q · filed 2022-11-10 |
| 2022-06-30 | $126.24K 10-Q · filed 2022-08-05 |
| 2022-03-31 | $189.36K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $252.48K 10-K · filed 2022-03-17 |
| 2021-09-30 | $60.78K 10-Q · filed 2021-10-28 |
| 2021-06-30 | $121.56K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $182.34K 10-Q · filed 2021-05-06 |
| 2020-12-31 | $243.13K 10-K · filed 2021-03-11 |
| 2020-09-30 | $59.61K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $119.22K 10-Q · filed 2020-08-06 |
| 2020-03-31 | $178.84K 10-Q · filed 2020-05-07 |
| 2019-12-31 | $237.67K 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| iBio, Inc. (IBIO) | United States | $0.077B | -2.94 |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |